Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

4 terminated out of 129 trials

Success Rate

90.7%

+4.2% vs benchmark

Late-Stage Pipeline

2%

3 trials in Phase 3/4

Results Transparency

21%

8 of 39 completed with results

Key Signals

8 with results91% success

Data Visualizations

Phase Distribution

51Total
Not Applicable (47)
P 2 (1)
P 3 (1)
P 4 (2)

Trial Status

Completed39
Unknown33
Recruiting24
Active Not Recruiting12
Not Yet Recruiting9
Enrolling By Invitation7

Trial Success Rate

90.7%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (129)

Showing 20 of 20 trials
NCT00583817Not ApplicableEnrolling By Invitation

Endovascular Treatment of Thoracic Aortic Disease

NCT02306200Recruiting

Cardiovascular Health Improvement Project

NCT05800743Not ApplicableEnrolling By Invitation

Evaluation of the GORE® Ascending Stent Graft

NCT04907071Not ApplicableCompletedPrimary

Intravascular Ultrasound for the Evaluation of Malperfusion Syndrome in the Setting of Acute Aortic Dissection

NCT06827990Not ApplicableRecruitingPrimary

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

NCT07521488Not ApplicableNot Yet Recruiting

LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients

NCT04754217Recruiting

Valved Graft PMCF Study

NCT04746677Not ApplicableRecruiting

Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)

NCT07495267Not ApplicableNot Yet Recruiting

Nutritional Ketosis Marfan

NCT06550986Not ApplicableRecruitingPrimary

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study

NCT07387250Not ApplicableNot Yet RecruitingPrimary

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL)

NCT03894033Active Not RecruitingPrimary

Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection

NCT05639400Active Not Recruiting

Thoraflex Hybrid and Relay Extension Post-Approval Study

NCT04005976Recruiting

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

NCT06740721Not ApplicableNot Yet RecruitingPrimary

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA)

NCT03669055Not ApplicableCompletedPrimary

Hemodynamic Changes in the Aorta After Endovascular Treatment of the Aortic Dissection

NCT03707743Active Not RecruitingPrimary

Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)

NCT06966687Not ApplicableEnrolling By InvitationPrimary

Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)

NCT04937868Recruiting

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

NCT04966247Active Not Recruiting

Cerebral Protection in Aortic Arch Surgery

Scroll to load more

Research Network

Activity Timeline